Pharmacologic pearls for end-of-life care

American Family Physician

Volumn 79, Issue 12, 2009, Pages 1059-1065

  Clary, Patrick L ^a,c   Lawson, Philip ^b  

^a Exeter Hospital   (United States)

^b Littleton Regional Hospital   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ATROPINE; CORTICOSTEROID; DEXAMETHASONE; DIPHENHYDRAMINE; DRONABINOL; GLYCOPYRRONIUM BROMIDE; GRANISETRON; HALOPERIDOL; HYOSCYAMINE; KETAMINE; LACTULOSE; LORAZEPAM; MACROGOL; MAGNESIUM HYDROXIDE; METHADONE; METHYLPHENIDATE; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; NABILONE; NALOXONE; OCTREOTIDE; ONDANSETRON; OXYCODONE; PROCHLORPERAZINE MALEATE; PROMETHAZINE; RELISTOR; SCOPOLAMINE; SENNA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AIRWAY OBSTRUCTION; BEDTIME DOSAGE; CLINICAL PRACTICE; CONSTIPATION; DELIRIUM; DYSPNEA; EXCESSIVE RESPIRATORY SECRETION; HUMAN; INTESTINE OBSTRUCTION; LONG TERM CARE; LOW DRUG DOSE; MENTAL DISEASE; MENTAL HEALTH; NAUSEA; PAIN; PAIN ASSESSMENT; REVIEW; SUCTION DRAINAGE; TERMINAL CARE; VOMITING;

EID: 67649300612     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Qaseem A, Snow V, Shekelle P, et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice from the American College of Physicians. Ann Intern Med. 2008;148(2):141-146. (Pubitemid 351651556)
2. Lorenz KA, Lynn J, Dy SM, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008;148(2):147-159. (Pubitemid 351651557)
3. Morrison LJ, Morrison RS. Palliative care and pain management. Med Clin North Am. 2006;90(5):983-1004. (Pubitemid 44348817)
4. von Gunten CF. Interventions to manage symptoms at the end of life. J Palliat Med. 2005;8(suppl 1):S88-S94. (Pubitemid 43201797)
5. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer. Arch Intern Med. 2000;160(6):786-794.
6. Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev. 2001;(4):CD002066.
7. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnea. BMJ. 2003;327(7414):523-528. (Pubitemid 37088495)
8. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;(2):CD005623. (Pubitemid 351807383)
9. Krulewitch H, London MR, Skakel VJ, Lunstedt GJ, Thomason H, Brammel-Smith K. Assessment of pain in cognitively impaired older adults: a comparison of pain assessment tools and their use by nonprofessional caregivers. J Am Geriatr Soc. 2000;48(12):1607-1611.
10. Warden V, Hurley AC, Volicer I. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003;4(1):9-15. (Pubitemid 36163632)
11. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and survival at the end of life. J Pain Symp Man. 2006;32(6):532-540.
12. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA. 2005;293(24):3043-3052.
13. New Hampshire Hospice and Palliative Care Center. Opioid use guidelines. http://www.nhhpco.org/opioid.htm. Accessed April 23, 2009.
14. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th ed. Glenview, Ill.: American Pain Society; 2003.
15. Bradshaw M, Sen A. Use of a prophylactic antiemetic with morphine in acute pain: randomised controlled trial. Emerg Med J. 2006;23(3):210-213. (Pubitemid 44295349)
16. Herndon CM, Jackson KC II, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy. 2002;22(2):240-250. (Pubitemid 34112884)
17. Wilwerding MB, Loprinzi CL, Mailliard JA, et al. A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer. 1995;3(2):135-138.
18. Hallenbeck J. Fast fact and concept #15. Constipation. August 2005. 2nd ed. End-of-Life/Palliative Education Resouce Center. http://www.eperc.mcw.edu/ fastFACT/ff-015.htm. Accessed April 23, 2009.
19. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A suppl):11S-18S.
20. Miles CL, Fellowes D, Goodman ML, Wilkinson S. Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev. 2006;(4):CD003448. (Pubitemid 46841255)
21. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol. 1980;13(1):45-56. (Pubitemid 10164061)
22. McNicol ED, Boyce D, Schumann R, Carr DB. Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev. 2008;(2):CD006332. (Pubitemid 351807375)
23. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358(22):2332-2343. (Pubitemid 351749157)
24. Portenoy RK, Thomas J, Moehl Boatwright ML, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage. 2008;35(5):458-468. (Pubitemid 351601995)
25. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence based report. J Clin Oncol. 2001;19(9):2542-2554. (Pubitemid 32391226)
26. Okon T. Ketamine: an introduction for the pain and palliative medicine physician. Pain Physician. 2007;10(3):493-500. (Pubitemid 46971302)
27. Kripke BJ, Finck AJ, Shah NK, Snow JC. Naloxone antagonism after narcotic-supplemented anesthesia. Anesth Analg. 1976;55(6):800-805.
28. Jatoi A, Podratz KC, Gill P, Hartmann LC. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol. 2004;2(4):323-334. (Pubitemid 39409778)
29. Dunn GP. Palliating patients who have unresectable colorectal cancer: creating the right framework and salient symptom management. Surg Clin North Am. 2006;86(4):1065-1092. (Pubitemid 44189475)
30. Krouse RS, McCahill LE, Easson AM, Dunn GP. When the sun can set on an unoperated bowel obstruction: management of malignant bowel obstruction. J Am Coll Surg. 2002;195(1):117-128. (Pubitemid 34743004)
31. Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;(3):CD002764.
32. Ouellette J, Patterson L, Termuhlen P. Fast fact and concept #91. Interventional options for upper GI obstruction. December 2007. 2nd ed. End-of-Life/Palliative Education Resource Center. http://www.eperc.mcw.edu/ fastFact/ff-091.htm. Accessed April 23, 2009.
33. Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;(3):CD001219.
34. Markowitz AJ, Rabow MW. Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time... nothing was working". JAMA. 2008;299(15):1826.
35. Büttner M, Walder B, von Elm E, Tramèr MR. Is low-dose haloperidol a useful antiemetic?: A meta-analysis of published and unpublished randomized trials. Anesthesiology. 2004;101(6):1454-1463. (Pubitemid 39565004)
36. Breitbart W, Alici Y. Agitated and delirium at the end of life: "We could manage him". JAMA. 2008;300(24):2898-2910.
37. Jackson KC, Lipman AG. Drug therapy for delirium in terminally ill patients. Cochrane Database Syst Rev. 2004;(2):CD004770.
38. Lo B, Rubenfeld G. Palliative sedation in dying patients: "we turn to it when everything else hasn't worked". JAMA. 2005;294(14):1810-1816.
39. Boyle J. Medical ethics and double effect: the case of terminal sedation. Theor Med Bioeth. 2004;25(1):51-60. (Pubitemid 39137455)
40. Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev. 2008;(1):CD005177. (Pubitemid 351807578)
41. Wilders H, Menten J. Death rattle: prevalence, prevention, and treatment. J Pain Symptom Manage. 2002;23(4):310-317. (Pubitemid 34462943)